VIRGINIA: US pharmaceutical company Merck said on Friday (Saturday in Manila) that it will seek authorization of its oral drug molnupiravir for Covid-19 after it was shown to reduce by 50 percent the chance newly infected patients would be hospitalized.
A simple pill to treat the coronavirus has been sought since the start of the pandemic, and Friday's announcement was hailed as a major step towards that goal.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.